ClinicalTrials.Veeva

Menu

Diabetic Retinopathy and OCT-A Changes Post-cataract Surgery

U

Uptown Eye Specialists

Status

Unknown

Conditions

Cataract
Macular Edema Due to Diabetes Mellitus
Diabetic Retinopathy

Treatments

Procedure: Cataract surgery

Study type

Observational

Funder types

Other

Identifiers

NCT04660006
OCTa Study 1.0

Details and patient eligibility

About

The purpose of this study is to use optical coherence tomography angiography (OCT-A) to compare retinal vasculature after uncomplicated cataract surgery in patients with and without diabetic retinopathy.

Full description

Patients undergoing cataract surgery who provided informed consent were enrolled in the study. There were three comparison groups: control, diabetic retinopathy (DR) and diabetic macular edema (DME) groups. Optical coherence tomography angiography (OCT-A) scans measuring retinal thickness, vessel density, perfusion density, and foveal avascular zone were obtained at baseline and postoperative week one, month one and month three.

Enrollment

170 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients at Uptown Eye Specialists undergoing uneventful cataract surgery who have provided informed consent to the study.

Exclusion criteria

  • Other ocular co-morbidities such as axial length < 22.0 mm or > 25.0 mm, previous ocular surgeries, previous history of uveitis, previous ocular trauma, cornea pathologies or glaucoma, intraocular pressures over 22 mmHg
  • In groups 1 and 2: previous retinal laser treatments
  • OCT-A signal strength < 6
  • Use of multifocal intraocular lens
  • Second eye (if first eye recruited)
  • In Group 1: No diabetes mellitus as past medical history

Trial design

170 participants in 3 patient groups

Control
Description:
Patients undergoing uneventful cataract surgery with no retinal vascular disease.
Treatment:
Procedure: Cataract surgery
Diabetic Retinopathy (DR)
Description:
Patients with non-proliferative diabetic retinopathy with no diabetic macular edema treatment in the 6 months prior to uneventful cataract surgery.
Treatment:
Procedure: Cataract surgery
Diabetic Macular Edema (DME)
Description:
Patients with diabetic macular edema undergoing active Anti-VEGF treatment (within the last 3 months) undergoing uneventful cataract surgery.
Treatment:
Procedure: Cataract surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems